Who Owns Adaptive Biotechnologies (ADPT)? 13F Institutional Holders (Q2 2026)

ADPT ranks #2106 out of 37696 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

ADPT is a disclosed holding of Andreas Halvorsen (Viking Global Investors), one of the tracked superinvestors on AlphaSMO — it makes up 1.8% of that fund's own 13F portfolio.

ADPT is a top-conviction position for Blue Water Life Science Advisors, LP — at 13.7% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in ADPT belongs to Viking Global Investors LP, but the position matters far more to Blue Water Life Science Advisors, LP, who has 13.7% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

Edge Wealth Management LLC has added to its ADPT position for two straight quarters, increasing it by $1.3M to reach $2.5M today.

ADPT is down 6.1% today, but institutions show net buying of $439.2M this quarter — a divergence between today's price move and the underlying institutional flow.

ADPT reported a net loss of $63.9M over the trailing twelve months.

• Not yet profitable — net loss of $63.9M over the trailing twelve months
• Revenue grew 50.1% year over year
• Net income improved year over year, from -$121.2M to -$63.9M
• Operating cash flow was negative, using $46.0M in cash
• Current ratio of 3.34x — enough short-term assets to cover short-term liabilities
• Liabilities run 1.32x equity — within a conventional range